There are some things that are a given when it comes to your regular ob-gyn appointments: you'll probably get pee shy, the stirrups will be uncomfortable, and you'll obsess about what exactly is going through your doctor's head when she's poking around down there.
U.S. hospitals are rich with history, but Bellevue Hospital Center in New York City may be the quintessential American destination where some of the sickest patients— from past presidents to various immigrant groups in the 18th, 19th and 20th centuries— have sought care.
Seattle Genetics Inc said four people had died in trials testing its experimental cancer drug, prompting the U.S. Food and Drug Administration to impose a clinical hold on several early-stage studies.
After marijuana was legalized for adults in the U.S. state of Washington, younger teens there perceived it to be less harmful and reported using it more, a new study found.
A Georgia couple who used to struggle to get out of bed have worked to lose a combined 400 pounds, and said 2017 may be their best year yet as their lifestyle changes have given them more energy than they’ve had in years.
A Minnesota home builder who missed death by millimeters said he had to ask his friend to take a picture of his head to understand what happened when a nail wound up inches deep into his skull.
Nearly two decades ago, several drugs to treat rheumatoid arthritis hit the shelves in rapid succession, opening up a huge market for the treatment of the autoimmune joint disorder.
The U.S. Food and Drug Administration on Friday said it has approved Biogen Inc's drug to treat spinal muscular atrophy, the leading genetic cause of death in infants.
China, rocked in recent years by a series of food safety scandals, uncovered as many as half a million illegal food safety violations in the first three quarters of the year, an official said.
When her father's lung cancer worsened, Yin Min, a 51-year-old financial broker from Shanghai, faced a choice: pay nearly $3,000 a month for an approved drug or pay a fraction of the price for a generic drug not approved for use in China.